Board Meetings for PROLIFE

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
PROLIFEProlife Industries Limited14 Nov 2019Financial ResultsTo consider and approve the financial results for the period ended September 30, 2019
PROLIFEProlife Industries Limited02 Sept 2019Other business mattersTo consider other business matters
PROLIFEProlife Industries Limited30 May 2019Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2019 and dividend
PROLIFEProlife Industries Limited06 Nov 2018Financial ResultsTo consider and approve the financial results for the period ended September 30, 2018
PROLIFEProlife Industries Limited04 Sept 2018Other business mattersTo consider other business matters
PROLIFEProlife Industries Limited30 May 2018Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2018 and dividend
PROLIFEProlife Industries Limited09 Nov 2017Results/OthersInter alia, to consider, approve and take on record the Un-Audited Financial Results of the Company for the half year ended on September 30, 2017 and to transact other incidental and ancillary matters.
PROLIFEProlife Industries Limited18 Aug 2017Results/OthersTo consider inter alia: 1. To Approve and take on record the Financials and notes on accounts of the Company for the year ended on March 31, 2017. 2. To Consider and approve the Board's Report. 3. To appoint statutory auditor of the company for the financial year 2017-18. 4. To appoint secretarial auditor of the company for the financial year 2017-18 5. To open separate Bank Account for payment of Dividend 6. To approve notice of annual general meeting 7. To consider any other matter with permission of the Chair.
PROLIFEProlife Industries Limited26 May 2017Results/DividendTo consider inter alia: 1. Approve and take on record the audited financial results of the Company for the half year/year ended on March 31, 2017. 2. Recommend a final dividend, if any, on the equity shares of the Company for the year ended on March 31, 2017 for the approval of the shareholders at the ensuing Annual General Meeting.
Showing page 3 of 3 (39 total items)